Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 7, 2020 at 8:42 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via In the early days of the COVID-19 pandemic, Sanofi and Regeneron launched an ambitious plan to try out rheumatoid arthritis med Kevzara in desperately ill patients. But after early warning signs, a phase 3 flop has forced the drugmakers to can their U.S. trial.

    article source